K

KURA

KURA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio0% buys
BearishBullish
KURA Live QuoteReal-time
$7.35
$2.53(-25.61%)1M
Day Range$7.21 – $7.60
Open$7.30
Previous Close$7.34
Volume1.66M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$671.63M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-3.30
Price to Book38.3
Dividend Yield0.65%
Beta (Volatility)0.53
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $7.35 (8%)
Low: $6.75High: $13.90
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$32.00-78.7% upside

Insider Buys

0

$0

Insider Sales

6

$1.26M

Total Volume

$1.26M

6 transactions

Net Activity

$1.26M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
35CONFIDENCE

Sentiment Rating

Moderate Distribution

CEO Conviction Index

No Recent Signal

Key Drivers

  • •Heavy distribution: sales represent 100% of total transaction value.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
L
1

Leoni Mollie

Chief Medical Officer

0 buys1 sells

$440K total

P
2

Powl Brian T.

Chief Commercial Officer

0 buys1 sells

$345K total

B
3

Burrows Francis

Chief Scientific Officer

0 buys1 sells

$225K total

F
4

Ford Kathleen

COO

0 buys1 sells

$112K total

B
5

Bair Teresa Brophy

GC

0 buys1 sells

$89K total

Trading History
KURA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 28, 2026

1 months ago

Leoni Mollie

Chief Medical Officer

C-Level
Sell41.3K$10.67$440K

Sep 28, 2026

1 months ago

Powl Brian T.

Chief Commercial Officer

C-Level
Sell32.5K$10.63$345K

Sep 28, 2026

1 months ago

Ford Kathleen

COO

COO
Sell10.6K$10.59$112K

Sep 28, 2026

1 months ago

Bair Teresa Brophy

GC

General Counsel
Sell8.4K$10.50$89K

Sep 28, 2026

1 months ago

Doyle Thomas James

SVP, Finance, Accounting

SVP
Sell4.6K$10.50$48K

Sep 24, 2026

1 months ago

Burrows Francis

Chief Scientific Officer

C-Level
Sell20.7K$10.83$225K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
KURA Buy Conviction0%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.52B

KURA has an insider buy conviction of 0%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for KURA

Over the last 90 days, corporate insiders at KURA (KURA) engaged in a total of 6 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 6 were sales. The total volume of insider trading reached $1.26M.

The net insider activity for KURA shows a net selling bias of $1.26M. This activity represents a 0% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Leoni Mollie (Chief Medical Officer), who traded 41.3K shares valued at $440K on Sep 28, 2026.

Live Market News & Developments
Aggregated real-time headlines for KURA (KURA)
6 updates

After selling 448 shares, Brian T. Powl held 112,817 Kura Oncology (KURA) shares directly.

Stock Titan18h ago

Kura Oncology CCO Brian Powl sells $3,256 in shares By Investing.com

Investing.com UK16h ago

Chairman of Kura Oncology Picks Up 16% More Stock

Simply Wall St2d ago

KURA Stock Gains 37.6% in a Month: Here's What You Need to Know

Yahoo Finance80d ago

Insider Stock Purchases: November 17, 2026

Quiver Quantitative2d ago

Kura Sushi USA (NASDAQ:KRUS) Stock Rating Lowered by Northcoast Research

MarketBeat4d ago

FAQs About KURA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for KURA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for KURA is currently 35/100, which reflects a moderate distribution bias. This calculation accounts for a total of 0 purchases and 6 sales by company executives over the last 90 days.

The CEO Conviction Index for KURA is rated as "No Recent Signal". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.